Cargando…

Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766248/ https://www.ncbi.nlm.nih.gov/pubmed/29329348 http://dx.doi.org/10.1371/journal.pone.0191454

Ejemplares similares

Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer
por: Kim, Eric S., et al.
Publicado: (2017)

Correction to: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study
por: Jiang, Li, et al.
Publicado: (2023)

Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer
por: Ding, Qian, et al.
Publicado: (2013)

Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases
por: Li, Yue-Ya, et al.
Publicado: (2015)

Correction: Preclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by (18)F-ICMT-11-Positron Emission Tomography
Publicado: (2014)

Correction: Preclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by (18)F-ICMT-11-Positron Emission Tomography
por: Witney, Timothy H., et al.
Publicado: (2020)

Comparison of Carboplatin With Cisplatin in Small Cell Lung Cancer in US Veterans
por: Azar, Ibrahim, et al.
Publicado: (2022)

Correction to: Chemosensitizing and nephroprotective effect of resveratrol in cisplatin-treated animals
por: Osman, Abdel-Moneim M., et al.
Publicado: (2019)

Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients
por: Zhang, Guan-Zhong, et al.
Publicado: (2010)

Cisplatin/carboplatin cross-resistance in ovarian cancer.
por: Gore, M. E., et al.
Publicado: (1989)

Correction: EPS8 Inhibition Increases Cisplatin Sensitivity in Lung Cancer Cells
Publicado: (2014)

Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin
por: Tang, Chi-Hui, et al.
Publicado: (2010)

Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer
por: Huang, Liang, et al.
Publicado: (2017)

Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysis
por: Jiang, Shiyu, et al.
Publicado: (2021)

Cisplatin or carboplatin for advanced non-small cell lung cancer: does it really matter?
por: Kesireddy, Meghana, et al.
Publicado: (2021)

Oxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer
por: Yu, Jing, et al.
Publicado: (2015)

Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy
por: Shields, Lisa B E, et al.
Publicado: (2021)

Correction: Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib
por: Zhao, Bin, et al.
Publicado: (2019)

Comparison of Renal Functions Evaluated by Measured Glomerular Filtration Rate in Patients Treated With Cisplatin, Carboplatin, and Oxaliplatin
por: Choudhary, Rajnee, et al.
Publicado: (2023)

Correction: EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer
por: Wang, Xuemin, et al.
Publicado: (2015)

Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
por: Groen, H. J., et al.
Publicado: (1995)

Correction: Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells
por: Novohradsky, Vojtech, et al.
Publicado: (2018)

Safety and Efficacy of Weekly Paclitaxel and Cisplatin Chemotherapy for Ovarian Cancer Patients with Hypersensitivity to Carboplatin
por: Tate, Shinichi, et al.
Publicado: (2021)

Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single‑center, multi‑arm phase Ib study
por: Thein, Kyaw Z., et al.
Publicado: (2021)

Correction: Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
por: Barr, Martin P., et al.
Publicado: (2020)

Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation
por: Dieci, Maria Vittoria, et al.
Publicado: (2022)

Correction: Accuracy of Pulse Oximeters in Detecting Hypoxemia in Patients with Chronic Thromboembolic Pulmonary Hypertension
por: Kohyama, Tomoki, et al.
Publicado: (2015)

Correction to: Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis
por: Boonyawat, Kochawan, et al.
Publicado: (2020)

Correction: YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma
por: Yang, Chao, et al.
Publicado: (2022)

Cisplatin/5-Fluorouracil (5-FU) Versus Carboplatin/Paclitaxel Chemoradiotherapy as Definitive or Pre-Operative Treatment of Esophageal Cancer
por: Steber, Cole, et al.
Publicado: (2021)

Combined chemoradiation of cisplatin versus carboplatin in cervical carcinoma: a single institution experience from Thailand
por: Tharavichitkul, Ekkasit, et al.
Publicado: (2016)

Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy — a cohort study
por: Zahir, Muhammad Nauman, et al.
Publicado: (2017)

Correction to: Targeted therapy for cisplatin‐resistant lung cancer via aptamer‐guided nano‐zinc carriers containing USP14 siRNA
por: Zhao, Xinmin, et al.
Publicado: (2023)

Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
por: Liang, Sixian, et al.
Publicado: (2022)

Publisher Correction: Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft
por: Dozmorov, Mikhail G., et al.
Publicado: (2023)

Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer
por: Lee, Yun-Gyoo, et al.
Publicado: (2015)

Correction: Clinical characteristics and prognoses of patients treated surgically for metastatic lung tumors
por: Zhao, Xiaoliang, et al.
Publicado: (2019)

Correction to: A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients
por: Sun, Chaoyang, et al.
Publicado: (2020)

Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer
por: Kataoka, Nobutaka, et al.
Publicado: (2020)

Correction: Association of GWAS-Identified Lung Cancer Susceptibility Loci with Survival Length in Patients with Small-Cell Lung Cancer Treated with Platinum-Based Chemotherapy
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bflv4hmd131u6bjph62n26n069